This federal contract award is for the delivery of Ozempic medication to the Defense Logistics Agency (DLA), which is a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a total ceiling value of $3,133.30. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 17, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 3/17/25, 9:47 AM